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MACBackground: Species specific diagnosis of mycobacterial infection is crucial because
treatment of infections caused by Mycobacterium tuberculosis (MTB) differs from that of
non-tuberculous mycobacterial (NTM) species. The species identification used to be
cumbersome and non-reproducible a decade ago.
Objectives: Recently, some commercial tests have been made available to differentiate the
MTB and NTM growths in culture media. Sensitivity and specificity of these tests was
evaluated.
Materials and methods: In this double blind study 572 clinical samples were cultured in an
automated BACTEC-MGIT-960 system. A total of 147 (25.7%) samples were MGIT culture
positive. These cultures were subjected to an in-house m-PCR (which amplifies hsp-65,
esat-6 and ITS region for MAC), two commercial immune-chromatographic tests (ICTs)
and phenotypic tests.
Results: Of the 147 MGIT positive cultures, m-PCR was able to correctly identify MTB in 123
cultures and NTM in 24 which included 3 MAC isolates. m-PCR showed 100% agreement
with two gold standard methods-the nitrate reductase assay and PNB tests-in correctly
identifying MTB. Commercial strips were able to correctly identify MTB in 120 (97.5%) of
123 cultures, while 3 (2.5%) isolates were falsely identified as NTM. However, none of the
growth negative spent medium gave false positive results in any of the tests. None of the
commercial strips misidentified any of the 24 NTM as MTB; hence, specificity of these strips
was 100%. Of the 2 IC test systems, both SD Bioline and BD TBc strip tests missed 2.5% of
MTB isolates and misidentified these as NTM.
Conclusion: The in-house m-PCR was found to be the most accurate and efficient tool for
identifying the MTB, MAC and other NTMs.
 2014 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights
reserved.ved.
e, All India
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Early detection of tuberculosis (TB) is one of the key recom-
mendations of the World Health Organisation Stop-TB
strategy [1]. TB is mainly caused by Mycobacterium tuberculosis
(MTB), but non-tuberculousMycobacteria (NTM) can also cause
similar manifestations, under certain conditions, such as if
the host is immuno-compromised or if exposed to a very high
dose of NTM species. More than 45 mycobacterial species are
reported to be pathogenic or opportunistic pathogens to hu-
mans [2]. Despite similar clinical manifestations, the thera-
peutic regimen and course of treatment differ significantly
for MTB and NTM. Therefore, accurate and timely species-
specific diagnosis of mycobacterial infections becomes of par-
amount importance.
However, before identification of the species, it is important
that it grows in vitro for further phenotypic tests. The conven-
tional Lowenstein-Jensen (L-J) medium takes up to 60 days to
grow MTB to a detectable level. Hence, in 2007, the World
Health Organisation (WHO) recommended the use of an
automated liquid culture system, i.e., BACTECTM MGIT-960
(Mycobacterium Growth Indicator Tube 960 system) for rapid
detection and drug susceptibility tests as a standard method
for TB diagnosis [3]. However, the MGIT system does not pro-
vide information about the species grown. Hence, MGIT
flashed positive cultures need to be further confirmed by
Ziehl-Neelsen (Z-N) stained smear examination, whether the
growth is mycobacterium or some contaminating bacterial
growth [4], and then subculture is required on solid medium
for colony characteristics. Mycobacterial species of the growth
is confirmed by biochemical or molecular tests [5]. The differ-
entiation of MTB from NTM can be achieved by conventional
methods (growth rate, pigmentation of colonies and biochem-
ical features), selective inhibition tests, such as para-nitro
benzoic acid (PNB)/p-nitro-a-acetylamino-b-hydroxypropio-
phenone (NAP) and other commercial systems, recently
introduced in the market. Although conventional biochemical
methods are time-consuming, often requiring the use of
hazardous/carcinogenicchemicals (e.g.niacin test), andareprone
to subjective errors in the interpretation of results, these are
considered the standard methods. Currently, rapid immuno-
chromatographic tests (ICTs) have been developed that are based
on a predominant protein MPT-64 secreted by M. tuberculosis,
Mycobacterium africanum, and some strains ofMycobacterium bovis
[6–9]. ICTs provide quick results and hence WHO recommended
use of ICTs for species identification in positive cultures [3].
In recent years, molecular techniques have made deep in-
roads in TB diagnosis as they are highly sensitive, specific and
can be applied directly on different types of samples as well
as on grown cultures. Polymerase chain reaction (PCR)-based
methods have also been used for rapid detection and differ-
entiation of MTB and NTM [10]. However, monoplex PCRs
are bound to miss the co-infections and solo infections with
NTM. Therefore, in this study we used the standardized
in-house multiplex PCR (m-PCR) for the rapid detection and
differentiation of the M. tuberculosis, Mycobacterium avium
complex (MAC) and other non-tubercular mycobacterial
species in a single reaction [2,11,12].
In the present study, the efficacy of in-house m-PCR was
evaluated and compared with two commercial ICTs: SD Bio-line TB Ag MPT64 RapidTM and BD MGIT TBcTM identification
kits for their capabilities in differentiating MTB from NTM
in MGIT cultures.Materials and methods
Data collected between January 2010 and December 2011 were
analyzed retrospectively. All the samples which were
submitted to the laboratory for mycobacterial culture and
drug susceptibility testing as TB routine patient care service
were included in the study. Hence, no ethical clearance was
required for this study. However, all the study participants
gave informed consent, as a standard diagnostic procedure
of the laboratory, which is accredited by the central TB divi-
sion of the Government of India and certified by the Stop-
TB/WHO for non-commercial rapid culture and drug suscep-
tibility tests [13].Clinical specimens
In this study, a total of 572 clinical samples received from
patients with suspected TB were cultured in an automated
MGIT960 culture system. Of these, 125 were pulmonary
specimens and 447 were extra-pulmonary specimens, which
comprised of 123 CSF, 113 gastric aspirates, 49 pus, 55 pleural
fluids, 30 peritoneal fluids, 27 tissue, 14 lymph node aspirates,
18 synovial fluids, 4 pericardial fluids and 14 ascitic fluids.MGIT culture
Pulmonary and contaminated clinical specimens were
decontaminated by using NALC–NaOH method in a biosafety
cabinet, as described earlier [11]. The decontaminated speci-
mens (no decontamination of clean specimens) were inocu-
lated in the MGIT culture containing 800 ll of OADC and
PANTA supplement as per the manufacturer’s instructions
(Becton Dickinson Diagnostic Instrument Systems, Sparks,
MD, USA). The inoculated MGI tube was loaded in the auto-
mated BACTECTMMGIT-960 system and the growthwas contin-
uously monitored by BD Epi-center. From the flashed
positive culture tubes, Z-N smear examination and ICTs were
performed on the next working day. For this, 200 ll of suspen-
sion from MGIT culture was inoculated onto L-J medium for
phenotypic testing, and a 500 ll suspension was aliquoted
out for DNA extraction. All procedures were carried in a
biosafety-level 2B cabinet.DNA extraction from MGIT cultures
DNA isolation from the MGIT cultures was done as described
elsewhere [11,12,14]. Briefly, the culture pellets from the
0.5 ml culture suspensionswere lysedwith lysozyme followed
by proteinase-K-SDS treatment. Proteins andmacromolecules
were precipitated using NaCl and hexadecyltrimethylammo-
nium bromide solutions. Nucleic acids were recovered from
the aqueous phase after extraction with chloroform and iso-
amyl alcohol followed by precipitation with 70% ice cold etha-
nol. The resulting DNA pellets were solubilised in 1· Tris–
EDTA buffer and 5 ll were used for the multiplex PCR.
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The in-house m-PCR was performed according to the patented
protocol [15] as published previously [11,12]. This m-PCR tar-
gets hsp-65 (genus specific), esat-6 (MTB specific) and internal
transcribed spacer (ITS) MAC region (MAC specific). The se-
quences of primers were:
hsp-65 F- ACCAACGATGGTGTGTCCAT and
hsp-65 R- CTTGTCGAACCGCATACCCT;
esat-6 F- GCGGATCCCATGACAGAGCAGCAGTGGA and
esat-6 R- CCAAGCTTCCTATGCGAACATCCCAGTGACG;
ITS F- CCCTGA GACAACACTCGGTC and
ITS R- ATTACA CATTTCGATGAACGC.
PCR reactionwas set up for 25 ll final volumeandwas run in
a PTC-100 thermal cycler (MJ Research, USA) at the amplifying
conditions of initial denaturation at 95 C for 10min and 30 cy-
cles of 95 C for 1 min, 59 C for 1 min and 72 C for 1 min and a
final extension of 72 C for 10min. Amplified products were re-
solved through 2% agarose gel in Tris–acetate buffer. Target
bands of 441 bp for the genus specific, 320 bp for theM. tubercu-
losis and 144 bp forM. avium complex were visualized by stain-
ing with ethidium-bromide. All mycobacterial species must
amplify genus specific target and all MTB must amplify estat-6
region. If genus specific target is amplified but not the MTB or
MAC specific, it indicates other NTM than MAC (Fig. 1). The m-
PCR results were blinded to the person who carried out the ICT.
ICTs on mycobacterial culture
Two commercial assays, ‘‘BD MGITTM TBc Identification Test’’
(Becton, Dickinson & Company, Sparks, MD, USA) [16] and
‘‘SD BIOLINE TB Ag MPT 64 RapidTM’’ (Standard Diagnostics,
Inc., Korea) [17] were performed as per the manufacturer’s
instructions. Briefly, 100 ll of culture suspension from each
MGIT tube was added in the sample well of both strips and al-
lowed to flow up the pad; results were examined after 15 min
for the presence of a pink band in ‘‘Control’’ and ‘‘Test’’ re-
gions. The appearance of the control band confirmed the
validity of the test. If the control band was not visible, the test
was considered invalid and the samplewas retested. The pres-
ence of the control band alone indicates a negative result. The




Fig. 1 – Multiplex PCR amplifications of genus-specific 441 bp (h
specific (MAC) 144 bp (ITS region) targets. Lane, M-100 bp marke
complex; Lanes, 5,6-negative control; Lane 7- M. tuberculosis conresult, which was interpreted as the presence of MPT-64 anti-
gen, i.e.,MTB growth [18]. NTM culture is not detected by these
strips. Ninety-one flashed negative cultures were also sub-
jected to all three tests to check the specificity of each test.
Nitrate reductase assay
Nitrate reductase assay (NRA) was performed as a reference
test to confirm if the growth was MTB or not [19]. Briefly, 2
loopful colonies of 21–28 days old culture were emulsified in
0.2 ml of distilled water in the screw-cap tube. Two milliliters
of 0.01 M sodium nitrate substrate buffer was added into the
tube and placed in the water-bath at 37 C for 2 h. After that,
the tubes were removed from the water bath and one drop of
50% hydrochloric acid solution, two drops of 0.2% sulfanil-
amide solution and two drops of 0.1% N-naphthyl ethylenedi-
amine solution were added. The results were examined
immediately by reading the color visually by comparing with
the prescribedWHO color standards [20]. Only dark pink color
readings between 3+ and 5+ were considered positive results
for M. tuberculosis. In order to confirm the negative results, a
small amount of zinc powder was added to each negative
tube that should not develop any color to confirm the test re-
sult as being truly negative.
Para-nitro benzoic acid test (PNB)
All the culture isolates that showed negative results by both
ICTs and identified as Mycobacterium sp by PCR were further
subjected to the PNB test. The PNB was incorporated into the
L-J medium at a final concentration of 500 lg/ml which inhib-
its the growth of MTB [21]. Medium without any inhibitory
substance was considered as growth control. Five microliters
of McFarland 1 inoculum suspension was inoculated onto
the PNB and plain media and incubated at 37 C for 28 days.
Statistical analysis
The m-PCR results were analyzed and compared with ICT,
NRA and PNB assay as standard. The data were statically ana-
lyzed to calculate the sensitivity, specificity, Positive Predic-
tive Value (PPV) and Negative Predictive Value (NPV).     5        6        7        8       9
sp-65), MTB-specific 320 bp (esat-6) and M. avium complex-
r; Lanes, 1 &2-M. tuberculosis; Lane, 3-NTM; Lane, 4-M. avium
trol; Lane, 8- M. avium control and Lane, 9-negative control.
Fig. 2 – Algorithm of in-house multiplex PCR, SD Bioline, BD strip test, nitrate reductase and PNB testing on MGIT growth of
Mycobacteria. Cultures flashed negative after 42 days in MGIT 960 automated culture systemwere taken as negative controls.
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Out of 572 specimens, 147 were MGIT cultures flashed positive
and 425 were MGIT culture negative for Mycobacterium sp
(Fig. 2). All flashed positive and negative cultures were
checked for acid fast bacilli by Z-N stained smear examina-
tion (X1000) as per standard criteria. Of the 147 MGIT culture
positive growths, 52 mycobacterial cultures were from pul-
monary specimens and 95 from extra-pulmonary specimens
as shown in Table 1. From 425 flashed negative (spent) cul-
tures (after 42 days of incubation), at least 5 samples wereTable 1 – Evaluation of in-house multiplex PCR and two strip tes
and extra-pulmonary samples.
MGIT culture positive m-PCR (147) Strip test (147)
MTB NTM MAC SD Bioline B
Sputum (52/125) 45 6 1 45 4
CSF (34/123) 33 1 0 33 3
GA (18/113) 12 6 0 11 1
Pus (17/49) 14 3 0 14 1
Tissue (4/27) 2 1 1 1 1
Pleural fluid (10/55) 7 3 0 7 7
Peritoneal Fluid (5/30) 5 0 0 5 5
Lymph node (4/14) 3 0 1 2 2
Pericardial fluid
(1/4) 0 1 0 0 0
Synovial fluid (1/18) 1 0 0 1 1
Ascitic fluid (1/14) 1 0 0 1 1
Total (147/572) 123 21 3 120 1
MTB: M. Tuberculosis; NTM: non-tuberculous mycobacteria; MAC: M. aviu
SD Bioline: SD BIOLINE TB Ag MPT 64 Rapid test; BD: BD MGITTM TBc
Negative.
* Both ICT strips misidentified 3 MTB isolates.also selected randomly on the day of experimentation to
check the specificity of each test.
Multiplex-PCR was tested on 238 MGIT cultures, of which
147 were MGIT culture positive. Out of 147 positive cultures,
m-PCR detected all (100%) as mycobacterial growth-123
(83.67%) cultures as MTB, 21 (14.28%) other NTM, and 3
(2%) as MAC. All 91 MGIT negative cultures were negative
by m-PCR (Fig. 1, Table 1). In the strip test, all results were
valid as indicated by the presence of a control band (C
band). No significant difference was observed in band inten-
sity in two strip tests. Out of 147 MGIT positive cultures, 120t assays on Mycobacterium isolates isolated from pulmonary
NRA (147) PNB test (27)
D Negative (i.e. NTM) Pos Neg Pos Neg
5 7 45 7 7 0
3 1 33 1 1 0
1 7* 12 6 6 1
4 3 14 3 3 0
3* 2 2 2 1
3 7 3 3 0
0 5 0 0 0
2* 3 1 1 1
1 0 1 1 0
0 1 0 0 0
0 1 0 0 0
20 27 123 24 24 3
m complex.
Identification Test; PNB: para-nitro benzoic acid; Pos: positive; Neg:
Table 2 – Comparison of in-house multiplex PCR results with BD TBc identification strip, SD Bioline TB Ag MPT64 strip test,
nitrate reductase and PNB tests.
m-PCR (238) SD Bioline strip (238) BD TBc strip (238) NRA (147) PNB test (27)
Positive Negative Positive Negative Positive Negative Positive Negative
MTBC (123) 120 3 120 3 123 0 0 3
NTM (21) 0 21 0 21 0 21 21 0
MAC (3) 0 3 0 3 0 3 3 0
Negative (90) 0 91 0 91 – – – –
Total 238 238 147 27
Table 3 – Sensitivity, specificity, PPVand NPVof in-housemultiplex PCR as comparedwith strip tests and nitrate reduction and
PNB tests.




SD Bioline strip 100 97.5** 97.5 100
BD TBc Strip 100 97.5** 97.5 100
Nitrate test* 100 100 100 100
PNB test* 100 100 100 100
* Considered as confirmatory test for identification of MTB complex.
** Due to 3 false negative results obtained with strip tests.
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ative by both SD Bioline ICT and BD ICT strips (Tables 1
and 2). Hence both strips had the same sensitivity and
specificity.
Most notable performance of m-PCR was on 27 strip nega-
tive but MGIT and smear positive cultures. Of these, 3 (10.1%)
were detected as MTB, 21 (77.7%) as other NTM and 3 (10.1%)
as MAC. Of the 91 MGIT negative cultures, all were found neg-
ative by both ICT strip tests as well. Hence, the sensitivity and
specificity rates of ICT kits were 97.5% and 100% respectively,
as compared with m-PCR (Table 3).
NRA test and PNB test were used as standard methods. All
123 cultures that identified MTB in m-PCR showed positive
nitrate reduction test and identified these cultures as true
MTB. All 24 mycobacterial isolates that were identified as
NTM (21) and MAC (3) by m-PCR showed negative reaction
in nitrate tests (Tables 1 and 2).
Culture isolates that showed negative results by both the
ICTs andwere identified asMycobacterium by PCR were further
evaluated by a PNB test. Out of 27 ICTs negative, 24 isolates
were resistant and 3 isolates were sensitive to PNB. Thus,
these 3 isolates were truly detected as MTB by m-PCR, while
misidentified by both the ICTs (Tables 1 and 2). Hence, the
sensitivity and specificity of the m-PCR was 100% when com-
pared with the nitrate and PNB tests (Table 3). An excellent
agreement (Cohen’s kappa j = 1) was observed among
m-PCR, nitrate and PNB test for MTB detection.
Discussion
Recently, WHO estimated 8.7 million incident cases of TB and
1.4 million deaths occurred due to TB worldwide in 2011 [22].
Beside MTB infections, a significant percentage of patients are
infected by NTM, especially those co-infected with HIV [2,23].
Clinically, the symptoms of disease caused by NTM are oftensimilar to MTB disease. These patients are empirically pre-
scribed with standard anti-TB drugs which are inherently
ineffective against these NTM and most often these cases
are labeled MDR on the basis of smear examination. It is
mainly because in most of the resource-limited countries
where TB is endemic, facilities for species-specific identifica-
tion of the causative agent are lacking [24]. The treatment of
infections caused by NTM species and MTB is entirely differ-
ent. Though some NTM can be treated with simple antibiotics
in a few days, but for that correct species has to be identified
in order to initiate the appropriate treatment [25].
Mycobacterial growth on conventional L-J medium is fairly
identifiable if the growth is MTB. Rapid growers, photochrom-
ogenic and scotochromogenic mycobacteria can also be iden-
tified without much difficulty [19]. However, liquid cultures
have this limitation, though these provide a faster diagnosis
of TB. Hence after inclusion of liquid cultures in most of the
national TB control programmes, a number of ICTassays have
been developed to resolve this limitation. Most of these are
based on the presence of MPT-64 and/or MPT-63 antigens in
MTB, but not in NTM. The widely used commercial tests for
this purpose are Capilia TB assay (Tauns Laboratories, Inc.,
Numazu, Japan), the Tibilia rapid test (Hangzhou, China),
the SD Bioline TB Ag MPT64 rapid test (Standard Diagnostics,
South Korea), and the BD MGIT TBc identification test. MPT-64
protein was first used for rapid detection of MTB by the
researchers in Japan which showed excellent specificity and
sensitivity [4,5,10,26–30].
However, these tests can be applied only after a significant
growth has taken place in the medium which takes several
days to weeks. To minimize this duration, several nucleic
acid amplification assays (NAAT) have been developed,
which are already commercialized or undergoing clinical
evaluation. Centers for Disease Control and Prevention
(CDC) and the American Thoracic Society (ATS) recommend
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of patients with signs and symptoms of pulmonary TB
[31,32]. Even though these monoplex NAATs are well ac-
cepted, they are bound to miss the co-infections and infec-
tions with NTM. To overcome this limitation, an in-house m-
PCR was developed which provides rapid detection and differ-
entiation of the M. tuberculosis, M. avium complex and other
NTM species in a single reaction tube [11,12,15].
The present study demonstrated the superiority of the in-
house multiplex-PCR in comparison with two commercial
ICT assays: BD MGITTM TBc identification and SD Bioline TB
AgMPT64 rapid strip tests, in terms of species specific identi-
fication of mycobacteria. When compared with standard and
reference phenotypic assays, the in-house m-PCR showed
100% sensitivity and specificity in MTB detection. However,
the two commercial strips could achieve only 97.5% sensitiv-
ity. Three isolates identified as MTB by m-PCR were missed by
both ICT tests. All three isolates were identified as MTB by
NRA and PNB tests as well. Thus, m-PCR was able to detect
MTB truly in all cases. The in-housem-PCR amplifies the novel
target esat-6 of the MTB which belongs to a cluster of five
genes in the region of differentiation-1 (RD1). This gene is con-
served only in M. tuberculosis complex species, Mycobacterium
kansasii and Mycobacterium marinum and is deleted from most
NTM species including M. bovis (BCG) strains. Therefore, even
though there is a possibility of false positive m-PCR (if
M. marinum orM. kansasii is present in the sample), these false
positive amplifications can be easily differentiated from MTB
specific amplification. The MTB complex will give a single
clear band while M. kansasii will show a pair of bands [23].
False negative results by strip test have also been reported
due to mutations [33,34], deletions [6,33], and IS6110/CG inser-
tions [33–35] in the coding region [6] of the mpt-64 gene. The
most frequent mutation reported was a 63-bp deletion at
position 196 in 10 isolates from Japan, Taiwan, and Thailand
and was later identified at species level [36]. It has been
reported that insertion in the mpt-64 gene in the nucleotide
position 324, 108 codon, changing the primary structure of
half protein and introducing an end signal (TGA) at nucleotide
498, codon 167 in the reading frame [5].
The results of the present study show that both SD Bioline
TB Ag MPT64 RAPID and BD MGITTM TBc identification tests
show identical performance, but both have lower sensitivity
missing at least 3 MTB isolates. In contrast our in-house
m-PCR was found to be more sensitive than these commercial
ICT strips. It was rapid in identifying and differentiating MTB
complex, MAC and other NTM in liquid as well as solid cul-
tures. The m-PCR showed 100% sensitivity, specificity and
agreement with phenotypic reference tests.
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